NEWS
Accuray Receives CE Mark for a New Helical Radiation Delivery System, Accuray Helix™
Accuray Incorporated (NASDAQ: ARAY) has received CE Mark for Accuray Helix™, a new CT-guided helical radiotherapy system designed for emerging markets with access to advanced cancer care. The system aims to provide high-performance, high-throughput radiotherapy in non-urban communities, offering short treatment times and cost-effectiveness.
Accuray Helix is part of the company's strategic plan to expand its portfolio of helical radiation therapy delivery systems. It's designed to treat routine cancer cases including breast, cervix, head and neck, gastrointestinal, lung, and prostate. The system's flexibility and versatility aim to improve personalized patient care while boosting clinic productivity to meet growing cancer care demands.
Accuray Helix is part of the company's strategic plan to expand its portfolio of helical radiation therapy delivery systems. It's designed to treat routine cancer cases including breast, cervix, head and neck, gastrointestinal, lung, and prostate. The system's flexibility and versatility aim to improve personalized patient care while boosting clinic productivity to meet growing cancer care demands.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
Spread kindness and love. Life is short. Don’t let greed eat you.
2330Followers
106Following
24KVisitors
Follow